Reach7 Diabetes Studio
Health & Wellness · Other Health & Wellness Businesses
Description
What is Reach7 Diabetes Studio?
Diabetes and weight management care via retail studios with 24/7 remote biometric monitoring
Reach7 Diabetes Studios: The First Concierge Franchise for Diabetes and Weight Management
The Market Opportunity: The U.S. is facing a massive metabolic crisis with over 40 million Americans living with diabetes and 100 million struggling with obesity. At the same time, a severe national shortage of endocrinologists has created 6-to-12 month wait times for patients desperately seeking care. Reach7 Diabetes Studios is capturing this massive, underserved market as the first membership-based, retail franchise dedicated exclusively to diabetes, prediabetes, and weight management.
The Business Model: Reach7 operates on a highly lucrative, $299/month cash-pay membership model. For franchisees, this means immediate, predictable recurring revenue with zero reliance on insurance reimbursements, claim denials, or administrative "red tape". Our modern studios require a small, cost-effective retail footprint (1,400–1,600 sq ft) and are strategically located next to high-traffic anchors like Publix grocery stores to drive organic walk-in visibility. Because of the recurring revenue structure, a typical studio only needs about 300 members to achieve profitability.
The "Unfair Advantage":
• Proprietary AI Technology: Our proprietary clinical decision support software (Diasyst) empowers mid-level practitioners (Nurse Practitioners and Physician Assistants) to safely deliver specialist-level outcomes. This completely removes the primary barrier to scaling healthcare: the need to hire scarce, expensive specialists.
• First-Mover Status: There is currently no direct franchise competition in this specific "medical-to-retail" space. Franchisees are getting in at the ground level of a category-defining brand.
• "Phygital" Scale: We combine the high-touch accountability of in-person retail visits with a highly scalable 24/7 remote biometric monitoring system, creating incredible patient "stickiness," exceptional clinical outcomes, and long-term retention.
Ideal Franchisees: Reach7 provides a fully turnkey, asset-light investment opportunity ideal for:
• Medical Providers (MDs, DOs, NPs, PAs) looking to own their own independent practice, escape the burnout of the insurance system, and monetize their existing patient panels.
• Business Executives & Investors seeking a recession-resistant, high-margin asset with proven operational playbooks and a recurring revenue stream.
• Existing Healthcare Owners (e.g., urgent care, dialysis centers, or retinal surgeons) who want a synergistic business where they can refer their existing diabetic patients.
Reach7 isn't just another clinic; it is a scalable, tech-enabled platform poised to redefine chronic care while delivering exceptional unit economics for its franchise partners.
- Diabetes specialization
- Studio-based format
- Boutique health model
- Diabetes-focused programming
Location Analysis
Where Reach7 Diabetes Studio wins
Is your territory available?
We'll take you through a few quick questions, then Reach7 Diabetes Studio confirms availability directly.
Financial Analysis
The numbers behind Reach7 Diabetes Studio
Financing partners
Vetted partners, tailored to franchisees
Your Franzy advisor can connect you with these partners later in the process — competitive rates, specialized in franchise financing.
FranFund
CRF USA
Nonprofit SBA lender; provides financing for franchise acquisitions, startups, and expansion.
First Bank of the Lake
Pension Pros
The model
How Reach7 Diabetes Studio works
Owner stays in an executive role — sets strategy, hires a manager, and oversees crews. Typically 5–20 hr/wk after ramp; many keep their day job.
Owner runs the business as their primary job — leads the team day-to-day on the ground, 40+ hr/wk.
Sells to businesses, contractors, or property owners.
Sells directly to consumers and homeowners.
Serves both businesses and consumers.
FDD Item 7
Initial investment range
The investment range midpoint (from range reported on Item 7) is $523,805 and financing can reduce cash-at-close by 80–90%.
Over time
Franchise footprint
No units disclosed — 1 filing running
Every FDD Item 20 on file reports zero — a clean record, not a gap in our data.
2025 Franchise Disclosure
FDD documents
Below are items 2, 3, 4, 7, 11 and 19 for Reach7 Diabetes Studio's 2025 FDD. The complete FDD is delivered to you directly by the franchisor, per the FTC Franchise Rule.
Connect to download Items 2, 3, 4, and 11 — direct from the franchisor.
Buyer FAQs
Frequently asked questions
The initial investment for a Reach7 Diabetes Studio franchise typically ranges between $429,110.00 and $618,500.00. This includes the franchise fee, equipment, real estate, and other startup costs. To get a detailed breakdown and better understand the financial requirements, we recommend scheduling a call with the Franzy team. We'll walk you through the specifics and answer any questions you might have. For more detailed information, refer to the financial sections of the FDD.
Disclaimer. The information provided on this page is based on the latest Franchise Disclosure Document (FDD) we have on record, which was issued in 2025. This information is for informational purposes only and is not intended to constitute legal, financial, or business advice. We make no guarantees or claims regarding the completeness or accuracy. Only the franchisor can confirm that the information is complete and accurate and we recommend consulting the franchisor directly for the most recent FDD and regarding any questions that you may have about the information provided.
